RESULTS	In a Phase II , open , randomised , multicentre trial 180 children aged 6 months to 17 years received two injections , 21 days apart , of vaccine containing either : 30 microg haemagglutinin ( HA ) with adjuvant ( 30 microg + Al ) or 7.5 microg HA without adjuvant .\